Galera Therapeutics, Inc. / Estimates

    Fiscal Year Revenue Net income Net margin Free cash flow FCF margin
    €0.00 +NaN% -€16.33M -67.9% N/A -€10.46M -72.9% N/A
    €0.00 +NaN% -€50.90M -5.0% N/A -€38.59M +3.2% N/A
    €0.00 +NaN% -€53.61M -22.7% N/A -€37.39M -35.9% N/A
    €0.00 +NaN% -€69.38M +8.5% N/A -€58.31M +14.5% N/A
    €0.00 +NaN% -€63.94M +42.9% N/A -€50.90M +28.4% N/A
    €0.00 +NaN% -€44.74M +119.3% N/A -€39.66M +111.0% N/A
    €0.00 +NaN% -€20.40M +0.6% N/A -€18.80M -5.5% N/A
    €0.00 -€20.29M N/A -€19.89M N/A

    Notifications